NCT02599012

The Efficacy of Intravenous Iron for the Treatment of Anemia in Cancer Patients

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Samsung Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

* Multifactorial pathogenesis is involved in anemia of cancer patients and defining the causes of anemia is not always simple. * Currently, treatment options available for anemia in cancer patients include red blood cell (RBC) transfusion, erythropoietin stimulating agent (ESA), and iron supplementation, accompanying considerable pros and cons for each treatment. * Previous studies have demonstrated benefit when treating with IV iron in combination with ESA and, more recently, evidence is emerging to suggest a role for IV iron alone. * In this study, investigator will assess the efficacy of intravenous iron for the treatment of anemia in cancer patients.

Conditions

• Cancer
• Anemia

Interventions

Type	Name	Description
DRUG	Ferinject®	intravenous Ferinject 1000mg injection

Timeline

• Start date: 2015-09-12
• Primary completion: 2017-10-01
• Completion: 2017-12-01
• First posted: 2015-11-06
• Last updated: 2017-02-09

Locations

1 site across 1 country: South Korea